Independent clones at separable stages of differentiation, bearing different GATA1 mutations, in the same TMD patient with Down syndrome

Authors:

Abstract
A female DS neonate (patient TMD2 in a previous report2) presented with typical symptoms of TMD; 2 days after birth, a peripheral-blood (PB) sample was taken from which an aliquot was sorted for CD34+ and CD34- blast-cell populations. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis (Figure 1B) detected the full-length GATA1 transcript as well as a shorter transcript lacking exon 2 (spliceΔ-exon 2) in the patient's presentation sample and the CD34- cells, whereas her CD34+ cells lacked the full-length product. Sequencing of the RT-PCR product from the unsorted presentation sample2 revealed a 34-base pair (bp) duplication in GATA1 exon 2. However, cloning of the RT-PCR products revealed additional mutations, each causing translation of a typically truncated6 GATA1 protein. Unsorted and CD34- cells were found to carry 3 different mutations (dup34, ins8, and dup4; Figure 1Ci-iii), which were present on different chromosomes and represent independent clonal proliferations (not shown). CD34+ cells carried spliceΔ-exon 2 as the sole form of GATA1 transcript (Figure 1Civ). Genomic DNA cloning and sequencing from these CD34+ cells revealed the ins8 and dup4 mutations, but not the dup34 mutation (not shown). This was confirmed by PCR amplification from genomic DNA using dup34-allele-specific primers (Figure 1D), which amplified the specific product in the presentation sample but not in CD34+ cells. Therefore, the dup34 of exon 2, a predominant change in the RNA of the presentation sample,2 could only have been contributed by the CD34-, and not CD34+, GATA1-expressing cells.